Manufacturing API, Drugs, and Excipients in America Act of 2020

H.R. 6930 · 116th Congress · May 19, 2020 · Lineage

A BILL

To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.

1. Short title

This Act may be cited as the “Manufacturing API, Drugs, and Excipients in America Act of 2020” or the “MADE in America Act of 2020”.

2. Table of contents

The table of contents of this Act is as follows:

Lineage

May 19, 2020viewing Introduced in House Mr. Carter of Georgia (for himself, Mr. Griffith, Mr. McKinley, Mr. Crawford, and Mr. Soto) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

Manufacturing API, Drugs, and Excipients in America Act of 2020

1. Short title

2. Table of contents

Cite this provision

Incoming references